This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
961.14(2)(nd)26.26. N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl acetylfentanyl; 2-methyl acetylfentanyl);
961.14(2)(nd)27.27. 2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl methoxyacetylfentanyl; 2-methyl methoxyacetyl fentanyl);
961.14(2)(nd)28.28. N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (para-methylfentanyl; 4-methylfentanyl);
961.14(2)(nd)29.29. N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide (phenyl fentanyl; benzoyl fentanyl);
961.14(2)(nd)30.30. N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide (thiofuranyl fentanyl; 2-thiofuranyl fentanyl; thiophene fentanyl).
961.14(2)(nm)(nm) Furethidine;
961.14(2)(p)(p) Hydroxypethidine;
961.14(2)(pm)(pm) Ketobemidone;
961.14(2)(q)(q) Levomoramide;
961.14(2)(qm)(qm) Levophenacylmorphan;
961.14(2)(qz)(qz) 2-methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one);
961.14(2)(r)(r) Morpheridine;
961.14(2)(rg)(rg) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
961.14(2)(rk)(rk) MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine);
961.14(2)(rm)(rm) Noracymethadol;
961.14(2)(s)(s) Norlevorphanol;
961.14(2)(sm)(sm) Normethadone;
961.14(2)(t)(t) Norpipanone;
961.14(2)(tm)(tm) Phenadoxone;
961.14(2)(u)(u) Phenampromide;
961.14(2)(um)(um) Phenomorphan;
961.14(2)(v)(v) Phenoperidine;
961.14(2)(vg)(vg) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);
961.14(2)(vm)(vm) Piritramide;
961.14(2)(w)(w) Proheptazine;
961.14(2)(wm)(wm) Properidine;
961.14(2)(wn)(wn) Propiram;
961.14(2)(x)(x) Racemoramide;
961.14(2)(xm)(xm) Synthetic Benzimidazole-opioid Substances, specifically including all of the following:
961.14(2)(xm)1.1. Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).
961.14(2)(xm)2.2. Etodesnitazene also known as Etazene (2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).
961.14(2)(xm)3.3. Etonitazene (2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).
961.14(2)(xm)4.4. Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5- nitro-1H-benzimidazol-1-yl)ethan-1- amine).
961.14(2)(xm)5.5. Isotonitazene (N,N -diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benizimidazol-1-yl)ethan-1-amine).
961.14(2)(xm)6.6. Metodesnitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine).
961.14(2)(xm)7.7. Metonitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine).
961.14(2)(xm)8.8. N-pyrrolidino etonitazene also known as etonitazepyne (2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole).
961.14(2)(xm)9.9. Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- propoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine).
961.14(2)(xr)(xr) Tilidine;
961.14(2)(y)(y) Trimeperidine.
961.14(2)(z)(z) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide).
961.14(2)(zm)(zm) Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol).
961.14(3)(3)Substances derived from opium. Any material, compound, mixture or preparation which contains any quantity of any of the following substances derived from opium, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(3)(a)(a) Acetorphine;
961.14(3)(b)(b) Acetyldihydrocodeine;
961.14(3)(c)(c) Benzylmorphine;
961.14(3)(d)(d) Codeine methylbromide;
961.14(3)(e)(e) Codeine-N-oxide;
961.14(3)(f)(f) Cyprenorphine;
961.14(3)(g)(g) Desomorphine;
961.14(3)(h)(h) Dihydromorphine;
961.14(3)(hm)(hm) Drotebanol;
961.14(3)(j)(j) Etorphine, except its hydrochloride salts;
961.14(3)(k)(k) Heroin;
961.14(3)(m)(m) Hydromorphinol;
961.14(3)(n)(n) Methyldesorphine;
961.14(3)(p)(p) Methyldihydromorphine;
961.14(3)(q)(q) Morphine methylbromide;
961.14(3)(r)(r) Morphine methylsulfonate;
961.14(3)(s)(s) Morphine-N-oxide;
961.14(3)(t)(t) Myrophine;
961.14(3)(u)(u) Nicocodeine;
961.14(3)(v)(v) Nicomorphine;
961.14(3)(w)(w) Normorphine;
961.14(3)(x)(x) Pholcodine;
961.14(3)(y)(y) Thebacon.
961.14(4)(4)Hallucinogenic substances. Any material, compound, mixture or preparation which contains any quantity of any of the following hallucinogenic substances, including any of their salts, isomers, esters, ethers, and salts of isomers, esters, or ethers that are theoretically possible within the specific chemical designation, in any form contained in a plant, obtained from a plant, or chemically synthesized:
961.14(4)(a)(a) 3,4-methylenedioxyamphetamine, commonly known as “MDA”;
961.14(4)(ag)(ag) 3,4-methylenedioxyethylamphetamine, commonly known as “MDE”;
961.14(4)(am)(am) 3,4-methylenedioxymethamphetamine, commonly known as “MDMA”;
961.14(4)(ar)(ar) N-hydroxy-3,4-methylenedioxyamphetamine;
961.14(4)(b)(b) 5-methoxy-3,4-methylenedioxyamphetamine;
961.14(4)(bm)(bm) 4-ethyl-2,5-dimethoxyamphetamine, commonly known as “DOET”;
961.14(4)(c)(c) 3,4,5-trimethoxyamphetamine;
961.14(4)(cm)(cm) Alpha-ethyltryptamine;
961.14(4)(d)(d) Bufotenine;
961.14(4)(e)(e) Diethyltryptamine;
961.14(4)(f)(f) Dimethyltryptamine;
961.14(4)(g)(g) 4-methyl-2,5-dimethoxyamphetamine, commonly known as “STP”;
961.14(4)(h)(h) Ibogaine;
961.14(4)(j)(j) Lysergic acid diethylamide, commonly known as “LSD”;
961.14(4)(jm)(jm) 1-propionyl-lysergic acid diethylamide, commonly known as 1P-LSD;
961.14(4)(m)(m) Mescaline, in any form, including mescaline contained in peyote, obtained from peyote or chemically synthesized;
961.14(4)(mn)(mn) Parahexyl (3-hexyl-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo(b, d)pyran);
961.14(4)(n)(n) Phencyclidine, commonly known as “PCP”;
961.14(4)(p)(p) N-ethyl-3-piperidyl benzilate;
961.14(4)(q)(q) N-methyl-3-piperidyl benzilate;
961.14(4)(r)(r) Psilocybin;
961.14(4)(s)(s) Psilocin;
Loading...
Loading...
2021-22 Wisconsin Statutes updated through 2023 Wis. Act 272 and through all Supreme Court and Controlled Substances Board Orders filed before and in effect on November 8, 2024. Published and certified under s. 35.18. Changes effective after November 8, 2024, are designated by NOTES. (Published 11-8-24)